{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:29:48Z","timestamp":1791300588339,"version":"4.1.0"},"reference-count":25,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Mucopolysaccharidoses (MPS\u2019s) represent a subgroup of lysosomal storage diseases related to a deficiency of enzymes that catalyze glycosaminoglycans degradation. Mucopolysaccharidosis type I (MPS I) is a rare autosomal recessive disorder caused by a deficiency of \u03b1-l-iduronidase encoded by the IDUA gene. Partially degraded heparan sulfate and dermatan sulfate accumulate progressively and lead to multiorgan dysfunction and damage. The aim of this study is to describe the clinical, biochemical, and molecular characteristics of 13 Algerian patients from 11 distinct families. MPS I diagnosis was confirmed by molecular study of the patients\u2019 IDUA gene. Clinical features at the diagnosis and during the follow-up are reported. Eighty-four percent of the studied patients presented with a mild clinical phenotype. Molecular study of the IDUA gene allowed the characterization of four pathological variations at the homozygous or compound heterozygote status: IDUA NM_00203.4:c.1598C&gt;G-p.(Pro533Arg) in 21\/26 alleles, IDUA NM_00203.4:c.532G&gt;A-p.(Glu178Lys) in 2\/26 alleles, IDUA NM_00203.4:c.501C&gt;G-p.(Tyr167*) in 2\/26 alleles, and IDUA NM_00203. 4: c.1743C&gt;G-p.(Tyr581*) in 1\/26 alleles. This molecular study unveils the predominance of p.(Pro533Arg) variation in our MPS I patients. In this series, the occurrence of some clinical features linked to the Scheie syndrome is consistent with the literature, such as systematic valvulopathies, corneal opacity, and umbilical hernia; however, storage signs, facial dysmorphic features, and hepatomegaly were more frequent in our series. Screening measures for these debilitating diseases in highly consanguineous at-risk populations must be considered a priority health problem.<\/jats:p>","DOI":"10.3390\/ijms17050743","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T10:20:11Z","timestamp":1463480411000},"page":"743","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-2678","authenticated-orcid":false,"given":"Abdellah","family":"Tebani","sequence":"first","affiliation":[{"name":"Department of Metabolic Biochemistry, Rouen University Hospital, Rouen 76031, France"},{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lahouaria","family":"Zanoutene-Cheriet","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oran University Hospital, Oran 31000, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoubir","family":"Adjtoutah","sequence":"additional","affiliation":[{"name":"Department of Metabolic Biochemistry, Rouen University Hospital, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenaig","family":"Abily-Donval","sequence":"additional","affiliation":[{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"},{"name":"Department of Neonatal Pediatrics and Intensive Care, Rouen University Hospital, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Brasse-Lagnel","sequence":"additional","affiliation":[{"name":"Department of Metabolic Biochemistry, Rouen University Hospital, Rouen 76031, France"},{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Laquerri\u00e8re","sequence":"additional","affiliation":[{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"},{"name":"Pathology Laboratory, Rouen University Hospital, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Marret","sequence":"additional","affiliation":[{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"},{"name":"Department of Neonatal Pediatrics and Intensive Care, Rouen University Hospital, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla","family":"Chalabi Benabdellah","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oran University Hospital, Oran 31000, Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[{"name":"Department of Metabolic Biochemistry, Rouen University Hospital, Rouen 76031, France"},{"name":"Region-Inserm Team NeoVasc ERI28, Laboratory of Microvascular Endothelium and Neonatal Brain Lesions, Institute of Research for Innovation in Biomedicine, Normandy University, Rouen 76031, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"ref_1","unstructured":"Scrive, C., Beaudet, A.L., Sly, W., and Vaele, D. (2001). The Metabolic and Molecular Basis of Inherited Disease, Mc Graw-Hill."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/gim.2014.25","article-title":"The natural history of mps i: Global perspectives from the mps i registry","volume":"16","author":"Beck","year":"2014","journal-title":"Genet. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/0888-7543(92)90053-U","article-title":"Structure and sequence of the human \u03b1-l-iduronidase gene","volume":"13","author":"Scott","year":"1992","journal-title":"Genomics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00711309","article-title":"Review: The immunochemical analysis of enzyme from mucopolysaccharidoses patients","volume":"16","author":"Brooks","year":"1993","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/bj2740263","article-title":"\u03b1-l-Iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts","volume":"274","author":"Taylor","year":"1991","journal-title":"Biochem. J."},{"key":"ref_6","unstructured":"Human gene mutation database. Available online: http:\/\/www.hgmd.cf.ac.uk\/ac\/index.php."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/ajmg.a.32781","article-title":"Incidence of the mucopolysaccharidoses in Taiwan, 1984\u20132004","volume":"149","author":"Lin","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00431-011-1644-x","article-title":"Diagnosis and treatment trends in mucopolysaccharidosis I: Findings from the MPS I Registry","volume":"171","author":"Underhill","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1469-1809.1999.6310009.x","article-title":"Mucopolysaccharidosis type I: Characterization of a common mutation that causes Hurler syndrome in Moroccan subjects","volume":"63","author":"Alif","year":"1999","journal-title":"Ann. Hum. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1746-1596-6-39","article-title":"Molecular analysis of mucopolysaccharidosis type I in Tunisia: Identification of novel mutation and eight Novel polymorphisms","volume":"6","author":"Chkioua","year":"2011","journal-title":"Diagn. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.arcped.2007.06.018","article-title":"Mucopolysaccharidosis type I: Identification of alpha-l-iduronidase mutations in Tunisian families","volume":"14","author":"Chkioua","year":"2007","journal-title":"Arch. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1746-1596-6-47","article-title":"Mucopolysaccharidosis type I: Molecular characteristics of two novel alpha-l-iduronidase mutations in Tunisian patients","volume":"6","author":"Chkioua","year":"2011","journal-title":"Diagn. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1399-0004.2011.01680.x","article-title":"Mucopolysaccharidosis I mutations in Chinese patients: Identification of 27 novel mutations and 6 cases involving prenatal diagnosis","volume":"81","author":"Wang","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10545-010-9113-7","article-title":"Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I","volume":"33","author":"Thomas","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1096-7192(02)00200-7","article-title":"Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients","volume":"78","author":"Matte","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.GIM.0000078027.83236.49","article-title":"Can mucopolysaccharidosis type I disease severity be predicted based on a patient\u2019s genotype? A comprehensive review of the literature","volume":"5","author":"Terlato","year":"2003","journal-title":"Genet. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/humu.1380010412","article-title":"\u03b1-l-Iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype","volume":"1","author":"Scott","year":"1992","journal-title":"Hum. Mutat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/humu.9051","article-title":"Molecular analysis of 30 mucopolysaccharidosis type I patients: Evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations","volume":"20","author":"Venturi","year":"2002","journal-title":"Hum. Mutat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"E2189","DOI":"10.1002\/humu.21479","article-title":"IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: Identification and characterization of 35 novel \u03b1-l-iduronidase (IDUA) alleles","volume":"32","author":"Bertola","year":"2011","journal-title":"Hum. Mutat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380010204","article-title":"A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype","volume":"1","author":"Scott","year":"1992","journal-title":"Hum. Mutat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s004390100606","article-title":"Mutational analysis of 85 mucopolysaccharidosis type I families: Frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations","volume":"109","author":"Beesley","year":"2001","journal-title":"Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ajmg.a.32812","article-title":"Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein","volume":"149","author":"Vazna","year":"2009","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0009-8981(77)90466-1","article-title":"A method for the determination of amniotic-fluid glycosaminoglycans and its application to the prenatal diagnosis of Hurler and Sanfilippo diseases","volume":"79","author":"Whiteman","year":"1977","journal-title":"Clin. Chim. Acta"},{"key":"ref_25","unstructured":"Human genome variation society. Available online: http:\/\/www.hgvs.org\/mutnomen."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/743\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:24:02Z","timestamp":1760210642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/5\/743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5]]}},"alternative-id":["ijms17050743"],"URL":"https:\/\/doi.org\/10.3390\/ijms17050743","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]}}}